References for Methyl sulfonyl methane- MSM product – Hekma Center
0
$0.00
Mini Cart
  • Empty cart

    No products in the cart.

References for Methyl sulfonyl methane- MSM product

References for Methyl sulfonyl methane- MSM product

– Alam SS, Layman DL. Dimethyl sulfoxide inhibition of prostacyclin production in cultured aortic endothelial cells. Ann N Y Acad Sci . 1983; 411:318-320.

– Ameye LG, Chee WS. Osteoarthritis and nutrition. From nutraceuticals to functional foods: a systematic review of the scientific evidence. Arthritis Res Ther. 2006; 8(4):R127.

– Amirshahrokhi K, Bohlooli S, Chinifroush MM. The effect of methylsulfonylmethane on the experimental colitis in the rat . Toxicol Appl Pharmacol. 2011.

– Apps P, Mmualefe L, McNutt JW. Identification of volatiles from the secretions and excretions of African wild dogs (Lycaon pictus) . J Chem Ecol. 2012.

– Bal E, et al. The effects of gender difference on monocrotaline-induced pulmonary hypertension in rats. Hum Exp Toxicol. 2013.

– Balch, J. F. and Balch P.A., Prescription for Nutritional Healing, Avery Publishing, Garden City Park, NY, 1990.

– Barmaki S, et al. Effect of methylsulfonylmethane supplementation on exercise – Induced muscle damage and total antioxidant capacity . J Sports Med Phys Fitness. 2012.

– Barrager E, Schauss AG. Methylsulfonylmethane as a treatment for seasonal allergic rhinitis: additional data on pollen counts and symptom questionnaire . J Altern Complement Med. 2003.

– Barrager E., Veltmann J.R., Schauss A.G., Schiller R.N. A multi-centered, open label trial on the safety and efficacy of methylsulfonylmethane in the treatment of seasonal allergic rhinitis. J Altern Complement Med. 2002; 8:167-74.

– Beilke MA, Collins-Lech C, Sohnle PG. Effects of dimethyl sulfoxide on the oxidative function of human neutrophils. J Lab Clin Med. 1987; 110(1):91-96.

– Ben-Porath I, Weinberg RA. The signals and pathways activating cellular senescence . Int J Biochem Cell Biol. 2005.

– Berardesca E, et al. Clinical and instrumental evaluation of skin improvement after treatment with a new 50% pyruvic acid peel . Dermatol Surg. 2006.

– Berardesca E, Cameli N, Cavallotti C, Levy JL, Piérard GE, de Paoli Ambrosi G. Combined effects of silymarin and methylsulfonylmethane in the management of rosacea: clinical and instrumental evaluations. J Cosmet Dermatol. 2008; 7(1):8-14.

– Bertken R. “Crystalline DMSO”: DMSO2. Arthritis Rheum . 1983; 26(5):693-694.

– Brayton CF. Dimethyl sulfoxide (DMSO): a review . Cornell Vet. 1986.

– Brent A. Bauer. MSM for arthritis pain: Is it safe? Expert Answers, Mayo Clinic, July 9, 2009.

– Brien S, Prescott P, Bashir N, et al. Systematic review of the nutritional supplements dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) in the treatment of osteoarthritis. Osteoarthritis.Cartilage. 2008; 16(11):1277-1288.

– Brien S, Prescott P, Lewith G. Meta-analysis of the related nutritional supplements dimethyl sulfoxide and methylsulfonylmethane in the treatment of osteoarthritis of the knee. Evid. Based. Complement Alternat. Med. 2011; 2011:528403.

– Burdett N, McNeil JD. Difficulties with assessing the benefit of glucosamine sulphate as a treatment for osteoarthritis . Int J Evid Based Healthc. 2012.

– Burger BV, et al. Elemental sulfur identified in urine of cheetah, Acinonyx jubatus . J Chem Ecol. 2006.

– Caron JM, et al. Methyl sulfone induces loss of metastatic properties and reemergence of normal phenotypes in a metastatic cloudman S-91 (M3) murine melanoma cell line . PLoS One. 2010.

– Cecil KM, et al. Methylsulfonylmethane observed by in vivo proton magnetic resonance spectroscopy in a 5-year-old child with developmental disorder: effects of dietary supplementation . J Comput Assist Tomogr. 2002.

– Childs SJ. Dimethyl sulfone (DMSO 2 ) in the treatment of interstitial cystitis. Urol Clin North Am. 1994; 21:85-88.

– Clark T, et al. Why are dimethyl sulfoxide and dimethyl sulfone such good solvents . J Mol Model. 2008.

– Cordoba F, Nimni ME. Chondroitin sulfate and other sulfate containing chondroprotective agents may exhibit their effects by overcoming a deficiency of sulfur amino acids . Osteoarthritis Cartilage. 2003.

– Debbi EM, Agar G, Fichman G, et al. Efficacy of methylsulfonylmethane supplementation on osteoarthritis of the knee: a randomized controlled study. BMC. Complement Altern. Med. 2011; 11:50.

– Ebisuzaki K. Aspirin and methylsulfonylmethane (MSM): a search for common mechanisms, with implications for cancer prevention. Anticancer Res . 2003; 23(1A):453-458.

– Egorin MJ, et al. Plasma concentrations and pharmacokinetics of dimethylsulfoxide and its metabolites in patients undergoing peripheral-blood stem-cell transplants . J Clin Oncol. 1998.

– El-Gindy A, et al. Reflectance near-infrared spectroscopic method with Chemometric techniques for simultaneous determination of Chondroitin, glucosamine, and methyl sulfonyl methane . J AOAC Int. 2012.

– Engelke U.F., Tangerman A., Willemsen M.A., Moskau D., Loss S., Mudd S.H., Wevers R.A. Dimethyl sulfone in human cerebrospinal fluid and blood plasma confirmed by one-dimensional (1)H and two-dimensional (1)H-(13)C NMR. NMR Biomed. 2005 Aug; 18(5):331-6.

– Evans MS, Reid KH, Sharp JB Jr Dimethylsulfoxide (DMSO) blocks conduction in peripheral nerve C fibers: a possible mechanism of analgesia . Neurosci Lett. 1993.

– Ezaki J, et al. Assessment of safety and efficacy of methylsulfonylmethane on bone and knee joints in osteoarthritis animal model . J Bone Miner Metab. 2013.

– Feng L, et al. Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide . J Clin Invest. 1995.

– Fleck CA. Managing ichthyosis: a case study. Ostomy Wound Manage . 2006; 52(4):82-86, 88, 90.

– Gaby AR. Methylsulfonylmethane as a treatment for seasonal allergic rhinitis: more data needed on pollen counts and questionnaire. J. Altern. Complement Med. 2002; 8(3):229.

– Geba GP, et al. Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial . JAMA. 2002.

– Gumina S, et al. Arginine L-alpha-ketoglutarate, methylsulfonylmethane, hydrolyzed type I collagen and bromelain in rotator cuff tear repair: a prospective randomized study . Curr Med Res Opin. 2012.

– Hanno PM, Wein AJ. Medical treatment of interstitial cystitis (other than rimso-50/elmiron). Urology. 1987; 29:22-26.

– Herschler, R. J., “Methylsulfonylmethane in Cosmetics”, Cardinal Associates, Inc. 1984.

– Horváth K, Noker PE, Somfai-Relle S, Glávits R, Financsek I, Schauss AG. Toxicity of methylfulfonylmethane in rats. Food Chem Toxicol . 2002; 40(10):1459-1462.

– Hucker HB, Ahmed PM, Miller EA, et al. Metabolism of dimethyl sulphoxide to dimethyl sulphone in the rat and man. Nature. 1966; 209:619-620.

– Hwang PH, et al. PTEN/MMAC1 enhances the growth inhibition by anticancer drugs with downregulation of IGF-II expression in gastric cancer cells . Exp. Mol Med. 2005.

– Jacob SW and Herschler R. Introductory remarks: dimethyl sulfoxide after twenty years. Ann N Y Acad Sci. 1983; 411:12-17.

– Jafari N, et al. Cytotoxicity of methylsulfonylmethane on gastrointestinal (AGS, HepG2, and KEYSE-30) cancer cell lines . J Gastrointest Cancer. 2012.

– Jin HF, et al. Effects of endogenous sulfur dioxide on monocrotaline-induced pulmonary hypertension in rats . Acta Pharmacol Sin. 2008.

– Joksimovic N, et al. Efficacy and tolerability of hyaluronic acid, tea tree oil and methyl-sulfonyl-methane in a new gel medical device for treatment of haemorrhoids in a double-blind, placebo-controlled clinical trial . Updates Surg. 2012.

– Joung YH, et al. MSM enhances GH signaling via the Jak2/STAT5b pathway in osteoblast-like cells and osteoblast differentiation through the activation of STAT5b in MSCs . PLoS One. 2012.

– Kalman DS, et al. Influence of methylsulfonylmethane on markers of exercise recovery and performance in healthy men: a pilot study . J Int Soc Sports Nutr. 2012.

– Kantor ED, et al. Association between use of specialty dietary supplements and C-reactive protein concentrations . Am J Epidemiol. 2012.

– Kim LS, Axelrod LJ, Howard P et al. Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial. Osteoarthritis Cartilage . 2005 Nov 22.

– Kim LS, Axelrod LJ, Howard P, et al. Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial. Osteoarthritis Cartilage. 2006;14(3):286-294.

– Kim YH, et al. The anti-inflammatory effects of methylsulfonylmethane on lipopolysaccharide-induced inflammatory responses in murine macrophages . Biol Pharm Bull. 2009.

– Kirschmann, J. D. and Dunne, L. J., Nutrition Almanac, Second Edition, McGraw-Hill, 1984.

– Klandorf H, Chirra AR, DeGruccio A, Girman DJ. Dimethyl sulfoxide modulation of diabetes onset in NOD mice. Diabetes . 1989; 38(2):194-197.

– Kloesch B, et al. Dimethyl sulphoxide and dimethyl sulphone are potent inhibitors of IL-6 and IL-8 expression in the human chondrocyte cell line C-28/I2 . Life Sci. 2011.

– Kurihara-Bergstrom T, Flynn GL, Higuchi WI. Physicochemical study of percutaneous absorption enhancement by dimethyl sulfoxide: kinetic and thermodynamic determinants of dimethyl sulfoxide mediated mass transfer of alkanols . J Pharm Sci. 1986.

– Lawrence R. The effectiveness of the use of oral lignisul MSM (methylsulfonylmethane) supplementation on hair and nail health. 2002.

– Lawrence R, Sanchez D, Grosman M. Lignisul MSM (methylsulfonylmethane) in the treatment of acute athletic injuries. 2002.

– Lim EJ, et al. Methylsulfonylmethane suppresses breast cancer growth by down-regulating STAT3 and STAT5b pathways . PLoS One. 2012.

– Lin A, Nguy CH, et al. Accumulation of methylsulfonylmethane in the human brain: identification by multinuclear magnetic resonance spectroscopy. 2001; 123(2-3):169-177.

– Lleonart ME, Artero-Castro A, Kondoh H. Senescence induction; a possible cancer therapy . Mol Cancer. 2009.

– Magnuson BA, Appleton J, Ames GB. Pharmacokinetics and distribution of {35S}methylsulfonylmethane following oral administration to rats . J Agric Food Chem. 2007.

– Magnuson BA, Appleton J, Ryan B, Matulka RA. Oral developmental toxicity study of methylsulfonylmethane in rats. Food Chem Toxicol . 2007; 45(6):977-984.

– Marañón G, Muñoz-Escassi B, Manley W, et al. The effect of methyl sulphonyl methane supplementation on biomarkers of oxidative stress in sport horses following jumping exercise. Acta Vet Scand . 2008; 50:45.

– McCabe D, O’Dwyer P, Sickle-Santanello B, Woltering E, Abou-Issa H, James A. Polar solvents in the chemoprevention of dimethylbenzanthracene-induced rat mammary cancer. Arch Surg. 1986; 121(12):1455-1459.

– Methylsulfonylmethane (MSM). Monograph . Altern Med Rev. 2003.

– Mindell, Earl L., The MSM Miracle – Enhance your health with organic sulfur, Keats Good Health Guide, Keats Publishing, Inc., New Canaan, CT, 1997.

– Moazzami AA, Zhang JX, Kamal-Eldin A, et al. Nuclear magnetic resonance-based metabolomics enable detection of the effects of a whole grain rye and rye bran diet on the metabolic profile of plasma in prostate cancer patients. J Nutr. 2011; 141(12):2126-2132.

– Mohammadi S, et al. Protective effects of methylsulfonylmethane on hemodynamics and oxidative stress in monocrotaline-induced pulmonary hypertensive rats . Adv Pharmacol Sci. 2012.

– Montes LF, et al. Ultrastructural changes in the horny layer following local application of dimethyl sulfoxide . J Invest Dermatol. 1967.

– Morton JI and Siegel BV. Effects of oral dimethyl sulfoxide and dimethyl sulfone on murine autoimmune lymphoproliferative disease. Proc Soc Exp Biol. Med. 1986; 183:227-230.

– Murav’ev IuV, Venikova MS, Pleskovskaia GN, et al. Effect of dimethyl sulfoxide and dimethyl sulfone on a destructive process in the joints of mice with spontaneous arthritis [in Russian]. Patol Fiziol Eksp Ter. 1991; 2:37-39.

– Nakhostin-Roohi B, Barmaki S, Khoshkhahesh F, et al. Effect of chronic supplementation with methylsulfonylmethane on oxidative stress following acute exercise in untrained healthy men. J Pharm.Pharmacol. 2011; 63(10):1290-1294.

– Notarnicola A, Tafuri S, Fusaro L, et al. The “MESACA” study: methylsulfonylmethane and boswellic acids in the treatment of gonarthrosis. Adv. Ther. 2011; 28(10):894-906.

– O’Dwyer P, McCabe DP, Sickle-Santanello BJ, Woltering EA, Clausen K, Martin EW Jr. Use of polar solvents in chemoprevention of 1,2-dimethylhydrazine-induced colon cancer. Cancer . 1988; 62(5):944-948.

– Parcell S. Sulfur in human nutrition and applications in medicine . Altern Med Rev. 2002.

– Pearson TW, Dawson HJ, Lackey HB. Natural occurring levels of dimethyl sulfoxide in selected fruits, vegetables, grains, and beverages . J Agric Food Chem. 1981.

– Richmond VL. Incorporation of methylsulfonylmethane sulfur into guinea pig serum proteins. Life Sci. 1986; 39(3):263-268.

– Rizzo R, et al. Calcium, sulfur, and zinc distribution in normal and arthritic articular equine cartilage: a synchrotron radiation-induced X-ray emission (SRIXE) study . J Exp Zool. 1995.

– Rogovin JL. Accumulation of methylsulfonylmethane in the human brain: identification by multinuclear magnetic resonance spectroscopy . Toxicol Lett. 2002.

– Roninson IB. Tumor cell senescence in cancer treatment . Cancer Res. 2003.

– Rose SE, et al. Detection of dimethyl sulfone in the human brain by in vivo proton magnetic resonance spectroscopy . Magn Reson Imaging. 2000.

– Shackleford JM, Yielding KL. Ultrastructural studies of barrier restoration in epidermis of hairless mice following dimethyl sulfoxide application . J Cutan Pathol. 1984.

– Smale BC, Lasater NJ, Hunter BT. Fate and metabolism of dimethyl sulfoxide in agricultural crops . Ann N Y Acad Sci. 1975.

– Song Y, et al. Investigation of iminosulfuranes as novel transdermal penetration enhancers: enhancement activity and cytotoxicity . Pharm Res. 2005.

– Sweeney TM, Downes AM, Matoltsy AG. The effect of dimethyl sulfoxide on the epidermal water barrier . J Invest Dermatol. 1966.

– Thomas, C. Taber’s Cyclopedic Medical Dictionary, (1 7th Ed.). F.A. Davis Company, Philadelphia, PA. 1993.

– Total Health Magazine. “MSM”. Feb/Mar, 1998; Vol., 20 No. 1. pp. 30-31.

– Traub-Dargatz JL, McKinnon AO, Thrall MA, et al. Evaluation of clinical signs of disease, bronchoalveolar and tracheal wash analysis, and arterial blood gas tensions in 13 horses with chronic obstructive pulmonary disease treated with prednisone, methyl sulfonmethane, and clenbuterol hydrochloride. Am J Vet Res . 1992; 53(10):1908-1916.

– Tripathi R, Gupta S, Rai S, et al. Effect of topical application of methylsulfonylmethane (MSM), EDTA on pitting edema and oxidative stress in a double blind, placebo-controlled study. Cell Mol.Biol.(Noisy.-le-grand) 2011;57(1):62-69.

– Tsui T, et al. Understanding the role of scientific evidence in consumer evaluation of natural health products for osteoarthritis an application of the means end chain approach . BMC Complement Altern Med. 2012.

– Usha PR, Naidu MU. Randomised, double-blind, parallel, placebo-controlled study of oral glucosamine, methylsulfonylmethane and their combination in osteoarthritis. Clinical Drug Invest.  2004; 24:353-363.

– Werchan PM, et al. Right ventricular performance after monocrotaline-induced pulmonary hypertension . Am J Physiol. 1989.

– Whitaker, J., “Try MSM for Relief from Muscular Pain”, Health and Healing, Oct. 1997.

– Willemsen MA, et al. Methylsulfonylmethane (MSM) ingestion causes a significant resonance in proton magnetic resonance spectra of brain and cerebrospinal fluid . Neuropediatrics. 2006.

– Williams KI, Burstein SH, Layne DS. Dimethyl sulfone: isolation from cows’ milk . Proc Soc Exp Biol Med. 1966.

– Williams KI, Burstein SH, Layne DS. Metabolism of dimethyl sulfide, dimethyl sulfoxide, and dimethyl sulfone in the rabbit . Arch Biochem Biophys. 1966.

– Williams, S. Nutrition & Diet Therapy (8th ed.). Academic Press, N.Y., N.Y. 1997.

– Xie Q, Shi R, Xu G, Cheng L, Shao L, Rao J. Effects of AR7 joint complex on arthralgia for patients with osteoarthritis: results of a three-month study in Shanghai, China. Nutr J. 2008; 7:31.

– Yi HK, et al. Expression of the insulin-like growth factors (IGFs) and the IGF-binding proteins (IGFBPs) in human gastric cancer cells . Eur J Cancer. 2001.

– Zhang M, et al. Assessment of methylsulfonylmethane as a permeability enhancer for regional EDTA chelation therapy . Drug Deliv. 2009.

– Zhang M, et al. Topical metal chelation therapy ameliorates oxidation-induced toxicity in diabetic cataract . J Toxicol Environ Health A. 2011.

Leave us a comment

Cart Item Removed. Undo
  • No products in the cart.